LFST (LifeStance Health Group) PE Ratio: 160.83 (As of Jun. 24, 2026) — 32% Below Median


LFST LifeStance Health Group Inc LFST
57 GF Score
Price $9.65
GF Value $8.22
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group PE Ratio?

LifeStance Health Group LFST +2.22% 57 PE Ratio is 160.83 as of Jun. 24, 2026, which is 32% below its 10-year median of 236.67. GuruFocus rates LFST with a GF Score™ of 57/100 and a GF Value™ of $8.22 (Modestly Overvalued). The stock has 5 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-24), LifeStance Health Group's share price is $9.65. LifeStance Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06. Therefore, LifeStance Health Group's PE Ratio for today is 160.83.

During the past 7 years, LifeStance Health Group's highest PE Ratio was 370.00. The lowest was 105.17. And the median was 236.67.

LifeStance Health Group's EPS (Diluted) for the three months ended in Mar. 2026 was $0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.

As of today (2026-06-24), LifeStance Health Group's share price is $9.65. LifeStance Health Group's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06. Therefore, LifeStance Health Group's PE Ratio without NRI ratio for today is 158.20.

During the past 7 years, LifeStance Health Group's highest PE Ratio without NRI was 370.00. The lowest was 103.44. And the median was 235.38.

LifeStance Health Group's EPS without NRI for the three months ended in Mar. 2026 was $0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.

During the past 7 years, LifeStance Health Group's highest 3-Year average EPS without NRI Growth Rate was 47.20% per year. The lowest was 47.20% per year. And the median was 47.20% per year.

LifeStance Health Group's EPS (Basic) for the three months ended in Mar. 2026 was $0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.07.

Back to Basics: PE Ratio


LifeStance Health Group  (NAS:LFST) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


LifeStance Health Group PE Ratio Related Terms


LifeStance Health Group PE Ratio Historical Data

* Premium members only.

The historical data trend for LifeStance Health Group's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group PE Ratio Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial At Loss At Loss At Loss At Loss 352.00

LifeStance Health Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss 352.00 106.17

LFST vs NHC, BKD, CON: PE Ratio Comparison

For the Medical Care Facilities subindustry, LifeStance Health Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeStance Health Group PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's PE Ratio falls into.


LFST
57GF Score
LifeStance Health Group Inc LFST
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeStance Health Group PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

LifeStance Health Group's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=9.65/0.060
=160.83

LifeStance Health Group's Share Price of today is $9.65.
LifeStance Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 160.83 mean?
LifeStance Health Group (LFST) has a PE Ratio of 160.83 as of Jun. 24, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on LifeStance Health Group and its competitors. This is 32% below median its historical median of 236.67. Over the past decade, LifeStance Health Group's PE Ratio has ranged from 105.17 to 370.00.
Is LifeStance Health Group's PE Ratio too high?
LifeStance Health Group's current PE Ratio of 160.83 is 32% below median its 10-year median of 236.67. Over the past 10 years, this metric has ranged from a low of 105.17 to a high of 370.00. Overall, LifeStance Health Group has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's PE Ratio compare to NHC and BKD?
LifeStance Health Group's PE Ratio of 160.83 can be compared against companies in the Healthcare Providers & Services industry. Historically, LifeStance Health Group's own PE Ratio has ranged from 105.17 to 370.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Healthcare Providers & Services company?
A good PE Ratio depends on the Healthcare Providers & Services industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on LifeStance Health Group and its competitors. LifeStance Health Group's current PE Ratio is 160.83, which is 32% below median its own 10-year median of 236.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.22, compared to a current price of $9.65 — trading 17.4% above its estimated fair value. The current PE Ratio is 160.83, which is 32% below median its 10-year median of 236.67. LifeStance Health Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current PE Ratio is 160.83 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $9.65 is trading 17.4% above its estimated GF Value™ of $8.22. GuruFocus considers LifeStance Health Group to be Modestly Overvalued.

Key valuation signals for LFST:

  • PE Ratio: 160.83 (32% below median its 10-year median of 236.67)
  • GF Value™: $8.22 vs. price of $9.65 (17.4% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
57GF Score

Get the complete analysis for LFST

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.65
Price
$8.22
GF Value